WDAY is rated Sell at $127.83 versus the reconciled fair value midpoint of $95.27, implying -25.47% upside/downside. Confidence is separately disclosed at 87/100.
internal valuation cross-checks ($179) is recklessly anchored to an unsustainable 19% implied growth rate.
HCM Market Saturation: Core HCM market saturates fully, permanently capping organic top-line growth at low single digits.
WDAY is rated Sell at $127.83 versus the reconciled fair value midpoint of $95.27, implying -25.47% upside/downside. Confidence is separately disclosed at 87/100.
Position sizing playbook →| Market cap | $31.9B | |
|---|---|---|
| Revenue (ttm) | 9.6B | |
| Net income (ttm) | 693M | |
| EPS (ttm) | $2.59 | |
| Shares out | 249.7M | |
| P/E (trailing) | 49.4x | |
| P/E (forward) | 10.3x | |
| Volume | 4,252,722 | |
| Beta | 1.03 | |
| Price target | $203 | +58.4% |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2026-01-31 | Trend |
| Revenue | $5.14B | $6.22B | $7.26B | $8.45B | $9.55B | +16.8% |
| Gross profit | $3.71B | $4.51B | $5.49B | $6.38B | $7.23B | +18.1% |
| Operating income | $-116.0M | $-182.0M | $183.0M | $499.0M | $1.02B | — |
| Net income | $29.0M | $-367.0M | $1.38B | $526.0M | $693.0M | +121.1% |
| EPS (diluted) | $0.12 | $-1.44 | $5.21 | $1.95 | $2.59 | +115.5% |
| EBITDA | $377.0M | $206.0M | $752.0M | $1.08B | $1.47B | +40.5% |
| R&D | $1.88B | $2.25B | $2.46B | $2.63B | $2.68B | +9.3% |
| SG&A | $1.95B | $2.44B | $2.84B | $3.25B | $3.53B | +16.0% |
| Model | Fair value (mid) | Weight |
|---|---|---|
| Multi stage moat fade | $55.78 | 35% |
| Owner earnings | $145 | 25% |
| FCFF DCF | $116 | 25% |
| Forward earnings | $52.03 | 10% |
| Peg adjusted peer | $108 | 5% |
| Reverse DCF | $0.00 | 0% |
| Discounted earnings | $0.00 | 0% |
| Ddm | $0.00 | 0% |
| Residual income | $0.00 | 0% |
Recent company headlines from major financial publishers.
Workday successfully penetrates the massive financials market, sustaining double-digit growth while structurally reducing SBC. This execution drives robust GAAP margin expansion, allowing the stock to retain its premium multiple as it transitions into a mature compounder.
Top-line growth naturally decelerates as the core HCM market matures. The company generates massive operational cash flow, but true shareholder returns are structurally constrained by the ongoing need to issue and subsequently buy back stock to compensate engineering talent.
Intense competitive pressures and saturated core markets drive a rapid deceleration in growth. The market violently reprices the stock to reflect its GAAP unprofitability and heavily diluted mature growth profile, erasing years of premium valuation.
| Model | Weight | FV / share | vs spot | Contribution |
|---|---|---|---|---|
| Multi stage moat fade | 35% | $55.8 | -56.4% | |
| Owner earnings | 25% | $145 | +13.1% | |
| FCFF DCF | 25% | $116 | -9.3% | |
| Forward earnings | 10% | $52.0 | -59.3% | |
| Peg adjusted peer | 5% | $108 | -15.3% | |
| Reverse DCF | 0% | $0.00 | -100.0% | |
| Discounted earnings | 0% | $0.00 | -100.0% | |
| Ddm | 0% | $0.00 | -100.0% | |
| Residual income | 0% | $0.00 | -100.0% | |
| Composite FV (weighted) | 100% | $95.3 | -25.5% |
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 8.0% | $110 | $120 | $132 | $147 | $165 |
| 9.0% | $94.7 | $102 | $110 | $120 | $132 |
| 10.0% | $82.9 | $88.4 | $94.7 | $102 | $110 |
| 11.0% | $73.7 | $78.0 | $82.9 | $88.4 | $94.7 |
| 12.0% | $66.4 | $69.9 | $73.7 | $78.0 | $82.9 |
| Category | Weight | Score | Reading |
|---|---|---|---|
| Valuation | 11% | 5.0 | |
| Management | 11% | 6.7 | |
| Balance Sheet | 11% | 6.0 | |
| Profitability | 11% | 5.0 | |
| Revenue Growth | 11% | 6.0 | |
| Risk Assessment | 11% | 6.5 | |
| Competitive Moat | 11% | 9.0 | |
| Earnings Quality | 11% | 9.0 | |
| Capital Efficiency | 11% | 3.5 |
Upcoming earnings date and setup when available.